The association between the three species belonging to the "Streptococcus milleri" group and different sites of isolation was examined for 73 successive strains recovered from clinically significant, purulent infections. Susceptibility testing was performed on 64 of these strains. The present study supports the association of particular species with different clinical sources. Susceptibility data suggest that emerging penicillin resistance among Streptococcus anginosus and Streptococcus intermedius isolates may represent a potential clinical problem in the therapeutic management of infections caused by these species.
The "Streptococcus milleri" group is a heterogeneous complex of streptococci having a well-established role in serious pyogenic infections (9) . They are also recognized as common commensal organisms of the mouth, genitourinary tract, and gastrointestinal tract (12) . Despite the increasing awareness of the clinical significance of this group, its classification, nomenclature, and identification have not been elucidated until recently (3) . On the basis of molecular taxonomic studies performed by Whiley and Beighton, the "S. milleri" group is currently divided into three different species, Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius (14) . Those authors have also proposed a biochemical scheme for the phenotypic differentiation of these three species (16) . In addition, reliable test systems are now commercially available (1, 5) .
Although previous studies have evaluated the clinical significance and antimicrobial susceptibility of the "S. milleri" group as a whole (9, 12) , relatively few studies have examined either the clinical correlation (5, 6, 15, 16) or the antimicrobial susceptibility (6) of the three individual species as currently defined.
This study was undertaken to evaluate the differential antimicrobial susceptibilities of the three species belonging to the "S. milleri" group recovered from clinical specimens. The association between particular species and different sites of isolation was also examined.
A total of 73 successive unique strains of streptococci were recovered from clinically significant, purulent infections. Specimens were collected by either aspiration or a surgical procedure from November 1992 to December 1995. Only 26 strains (36%) were recovered in pure culture. Organisms had previously been identified as belonging to the "S. milleri" group by conventional tests, following the scheme recommended by Ruoff (13). Identification to the species level was performed according to the biochemical schedule proposed by Whiley et al. (16) . All strains were tested for production of ␣-galactosidase, ␤-galactosidase, ␣-glucosidase, ␤-glucosidase, ␤-Nacetylglucosaminidase, ␤-D-fucosidase, and sialidase by using 4-methylumbelliferyl-linked fluorogenic substrates (Sigma Chemical Co., St. Louis, Mo.) as described previously (13) . In addition, production of H 2 O 2 and fermentation of lactose, mannitol, and raffinose were examined (16) . Organisms were stored as frozen suspensions (Ϫ70ЊC) in tryptic soy broth containing 20% glycerol until use.
A total of 64 strains were available for susceptibility testing. Five antibiotics were selected in order to represent the main antimicrobial agents belonging to groups A and B suggested by the National Committee for Clinical Laboratory Standards for primary testing and reporting of streptococci other than Streptococcus pneumoniae (8) . The MICs of penicillin G, erythromycin, and streptomycin (Lepetit S.A., Buenos Aires, Argentina), gentamicin (Schering-Plough S.A., Buenos Aires, Argentina) and vancomycin (Eli Lilly Interamerica, Inc., Buenos Aires, Argentina) were determined by the agar dilution method with Mueller-Hinton agar (Difco Laboratories, Detroit, Mich.) supplemented with 5% sheep blood. Drug concentration ranges, obtained by serial twofold dilution, were as follows (in micrograms per milliliter): penicillin, 0.015 to 16; erythromycin, 0.125 to 8; vancomycin, 0.5 to 32; and gentamicin and streptomycin, 16 to 2,048. An inoculum was prepared by direct colony suspension from a 24-h blood agar plate and was applied with a Steers replicating device in order to reach roughly 10 4 CFU per spot. All plates were incubated in a 5% CO 2 atmosphere at 37ЊC for 24 h (8) . Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213 were used as controls. Antimicrobial breakpoints (except those for aminoglycosides) were adopted according to the National Committee for Clinical Laboratory Standards criteria (8) . Strains were classified for penicillin susceptibility as follows: susceptible, MIC of Յ0.125 g/ml; intermediately resistant, MIC of 0.25 to 2 g/ml; and resistant, MIC of Ͼ2 g/ml (8).
Organisms were considered to lack increased gentamicin or streptomycin resistance when the MICs for the organisms were below 64 g/ml. This concentration was adopted because certain viridans streptococcus strains for which the MICs are higher have proven by time-kill studies to be resistant to penicillin-aminoglycoside combinations (10) .
The results of the biochemical and enzymatic tests for most of the strains fit the scheme proposed by Whiley et al. (16) . Only two strains were negative for detection of ␣-galactosidase, ␤-galactosidase, ␣-glucosidase, ␤-glucosidase, ␤-N-acetylglucosaminidase, ␤-D-fucosidase, and sialidase, but they were as-sumed to be S. anginosus on the basis of H 2 O 2 production (16). S. anginosus was the most prevalent species (64.4%), followed by S. constellatus and S. intermedius (26 and 9.6%, respectively).
Anatomical sources were grouped as abdominal (17 abdominal abscesses, 15 samples of peritoneal fluid, and 2 samples from the biliary tract), urogenital (11 female genital tract abscesses and 3 samples from the urinary tract), head and neck (6 submandibular abscesses, 5 dental abscesses, and 1 sample from the nasal cavity), blood, skin and soft tissues (3 abscesses and 2 diabetic foot ulcers), and pleuropulmonary (1 lung abscess and 1 sample from a patient with empyema). The association between particular species and different isolation sites is given in Table 1 . S. anginosus was more frequently associated with abdominal and urogenital sites than the other two species (P Ͻ 0.05, chi-square test). S. intermedius was isolated more frequently from purulent head and neck specimens than from specimens from other body sites (P ϭ 0.05). Although S. constellatus appeared to be more prevalent in abdominal specimens than in head and neck and urogenital specimens, no statistically significant differences could be demonstrated. It should be stressed that only two pleuropulmonary and no central nervous system samples were included in our study.
In all, 40 S. anginosus, 18 S. constellatus, and 6 S. intermedius isolates were tested for antimicrobial susceptibility. Table 2 shows concentrations inhibiting 50% and 90% of strains, MIC ranges, and percent susceptibility obtained by using different antibiotics against these three species. A penicillin resistance rate of 12.5% (intermediately resistant, 9.4%; resistant, 3.1%) was found for the "S. milleri" group as a whole. Decreased susceptibility to penicillin was displayed by 12.5 and 5.5% of S. anginosus and S. constellatus strains, respectively. Two of six S. intermedius strains were intermediately resistant to penicillin. Only two strains (one S. anginosus strain and one S. constellatus strain) resistant to erythromycin were detected. No vancomycin resistance was observed in any isolate. No increased resistance to aminoglycosides was observed in any strain. "S. milleri" was originally coined in 1956 to describe certain nonhemolytic streptococci isolated from patients with oral infections (7) . At present, the "S. milleri" group is divided into three different species, S. anginosus, S. constellatus, and S. intermedius (14) . Numerous types of infections caused by this heterogeneous complex of streptococci have been reported (9, 12) , including fulminant septicemia in a previously healthy adult (4) and neonatal infection (11) . In addition, several authors have recently examined the association of the three species belonging to the "S. milleri" group with different sites of the body (5, 6, 15, 16) . Like these authors, we have observed that S. anginosus was the most prevalent species (64.4%) among the three species belonging to the "S. milleri" group, and it was more frequently associated with abdominal sites than either S. constellatus or S. intermedius. The association between S. anginosus and gastrointestinal sources has been assessed by Whiley et al. with clinical isolates from different laboratories in the United Kingdom (15) . However, other authors failed to clearly demonstrate such a correlation (5, 6) . In agreement with other reports (1, 5, 15, 16) , our study supports the evidence that S. anginosus is more frequently isolated from the genitourinary tract than the other two species. The close association between S. intermedius and liver abscesses or central nervous system infections is well established (5, 6, 15, 16 ), but we were unable to demonstrate an association for this species because these clinical sources were not included in our study. However, we have observed that S. intermedius was isolated more frequently from purulent head and neck specimens than from specimens from other body sites. Indeed, the high prevalence (66%) of this species among "S. milleri" group strains recovered from supragingival plaque from healthy subjects has been described (16) . We were only able to discern a trend of S. constellatus being more prevalent in abdominal specimens than in specimens from the head and neck and urogenital sites. Although other studies yielded similar results (5, 16) , one study including a large number of strains failed to demonstrate any specific clinical association for S. constellatus, with the possible exception of the respiratory tract (15) . It is noteworthy that that study included strains recovered at several centers, whereas our strains were successive isolates. Previous reports have evaluated the antimicrobial susceptibility of the "S. milleri" group as a whole (9, 12) , but few studies have examined this feature in the three individual species as currently defined (6) . In fact, these organisms have been widely considered susceptible to most antimicrobial agents, especially ␤-lactams and macrolides (9, 12) . In the present study, a penicillin resistance rate of 12.5% (intermediately resistant, 9.4%; resistant, 3.1%) was found for the "S. milleri" group, with S. anginosus showing more resistance than S. constellatus (12.5 versus 5.5%). Furthermore, two S. anginosus strains proved resistant to penicillin (MIC, 4 g/ml), while two of six S. intermedius strains were intermediate to penicillin. These findings differ from those published by Gómez-Garcés et al. (6) , who detected only two strains displaying decreased susceptibility to penicillin (MIC, 0.25 g/ml) among 70 clinical isolates. Those authors also reported a 14.3% of resistance to erythromycin (6) . In contrast, we found only two erythromycin-resistant strains (1 S. anginosus strain and 1 S. constellatus strain). Although streptomycin resistance has been well characterized in S. anginosus ("S. milleri") (2), no isolates displaying increased aminoglycoside resistance were detected in our study.
In summary, the present study supported the association of species belonging to the "S. milleri" group with different clinical sources. Furthermore, susceptibility data suggest that emerging penicillin resistance among S. anginosus and S. intermedius isolates may represent a potential clinical problem in the therapeutic management of infections caused by these species.
